Biotech Entrepreneur | AI & Computational Biophysics Expert
Combining 20+ years of interdisciplinary expertise in engineering, computer science, and biophysics to advance healthcare innovation through artificial intelligence and scientific modeling.
Nithin Dhananjayan is a California-based biotech entrepreneur and technology leader with over 20 years of experience spanning engineering, computer science, and biophysics. He holds a PhD in Biophysics from the University of California, Davis, where his research focused on computational studies of quinone binding in respiratory complex I, a fundamental component of cellular energy production.
With a Master's degree in Electrical Engineering from Stanford University, Nithin brings a unique interdisciplinary perspective to healthcare innovation. His expertise bridges the gap between advanced computational modeling, artificial intelligence, and practical medical device development. As the founder of Resilient Interface, Inc., he continues to push the boundaries of what's possible at the intersection of technology and healthcare.
Throughout his career, Nithin has demonstrated a commitment to both scientific excellence and community service. He has made over 425 platelet donations to Vitalant, actively participates in healthcare and biotech innovation communities, and provides consulting services in healthcare technology, educational development, and startup strategy, particularly in non-dilutive funding approaches.
University of California, Davis
2023
Dissertation: "Computational Studies of Quinone Binding in Respiratory Complex I"
Stanford University
Specialization in VLSI design, integrated circuits, and control systems
Photochemical & Photobiological Sciences, 2022
12 citations
This research quantifies the squeeze-in mechanism of quinone passage through the narrow entrance of the quinone binding site in respiratory complex I using advanced computational methods.
Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2021
20 citations
Investigation of the bottleneck structure at the quinone site entrance and the conformational changes required for quinone/quinol passage in respiratory complex I.
US Patent Application 16/685,984, 2020
4 citations
Patent for innovative medical device technology combining neurostimulation with RFID integration for enhanced patient care and device management.
I'm always interested in discussing new opportunities in healthcare innovation, biotech entrepreneurship, and collaborative research projects.